MedPath

A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects

Not Applicable
Conditions
Essential tremor
Registration Number
JPRN-UMIN000010714
Lead Sponsor
Tokyo Women's Medical University Shin-yurigaoka General Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

Unstable cardiac status Severe hypertension (diastolic BP > 100 on medication) Standard contraindications for MR imaging Severely impaired renal function History of abnormal bleeding and/or coagulopathy History of intracranial hemorrhage Infectioous or immunocompromise state Individuals who are not able or willing to tolerate the required prolonged stationary supine position during treatment Presence of any other neurodegenerative disease or Parkinsonism Presence of significant cognitive impairment as determined with a score ≤ 24 on the Mini Mental Status Examination

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Tremor improvement and evaluation of advers effect 12 months after treatment
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath